| 3QC4: reference: Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery., Erlanson DA, Arndt JW, Cancilla MT, Cao K, Elling RA, English N, Friedman J, Hansen SK, Hession C, Joseph I, Kumaravel G, Lee WC, Lind KE, McDowell RS, Miatkowski K, Nguyen C, Nguyen TB, Park S, Pathan N, Penny DM, Romanowski MJ, Scott D, Silvian L, Simmons RL, Tangonan BT, Yang W, Sun L, Bioorg Med Chem Lett. 2011 Mar 17. PMID: 21459573 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).